Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
American College of Physicians.
Guidelines for counseling postmenopausal women about preventive hormone therapy.
Ann Intern Med, 117 (1992), pp. 1038-1041
[2.]
Clinical Synthesis Panel on HRT..
Hormone replacement therapy.
Lancet, 354 (1999), pp. 152-155
[3.]
N.F. Santoro, N.F. Col, M.H. Eckman, J.B. Wong, S.G. Paunker, J.A. Cauley, et al.
Hormone replacement therapy –Where are we going?.
J Clin Endocrinol Metab, 84 (1999), pp. 1798-1812
[4.]
K.M. Newton, A.Z. Lacroix, S.G. Leveille, C. Rutter, N.L. Keenan, L.A. Anderson.
The physician's role in women's decision making about hormone replacement therapy.
Obstet Gynecol, 92 (1998), pp. 580-584
[5.]
M.J. Friedrich.
Recent studies bring risks, benefits of hormone replacement therapy under scrutiny.
J Natl Cancer Inst, 97 (2001), pp. 1287-1288
[6.]
D. Grady, S.R. Cummings.
Postmenoupausal hormone therapy for prevention of fractures: How good is the evidence?.
Jama, 285 (2001), pp. 1909-1910
[7.]
B. Vastag.
Hormone replacement therapy falls out of favor with expert committee.
Jama, 287 (2002), pp. 1923-1924
[8.]
J.M. Dixon.
Hormone replacement therapy and the breast: We should worry about the increase in the risk of breast cancer.
Bmj, 323 (2001), pp. 1381-1382
Copyright © 2002. Sociedad Española de Ginecología y Obstetricia